Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Medical Virology|July 9, 2020
Prevalence of hepatitis E virus in children from Northeast of ArgentinaAlfredo P Martínez, Matías J Pereson, Paula S Pérez, et al.
Ecancermedicalscience|December 3, 2025
Evaluating Ki-67 and PR as prognostic indicators in CDK4/6 inhibitor treatment for metastatic breast cancerMaría Florencia Illia, Giuliana Colucci, Angeles Ballester, et al.
JCO Oncology Practice|February 27, 2025
Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022Sofie Seghers, Pablo Mandó, Marc Eid, et al.
Breast Care (Basel, Switzerland)|January 2, 2023
Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast CancerMaria Del Rosario Sifón, Nicolas Marcolini, Maria Julia Barber, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2019
Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patientsEstefanía Paula Juliá, Pablo Mandó, Manglio Miguel Rizzo, et al.
JCO Global Oncology|April 22, 2020
Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National DatabaseVerónica Fabiano, Pablo Mandó, Manglio Rizzo, et al.
Breast Care (Basel, Switzerland)|February 26, 2019
Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients with ACOSOG Z0011 CriteriaCarlos Martin Loza, Pablo Mandó, Carolina Ponce, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|February 12, 2026
BRCA and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR+/HER2- breast cancer with germline BRCA1/2 mutations: a narrative reviewMaria Florencia Illia, Giuliana Colucci, Andres Rodriguez Mignola, et al.
Ecancermedicalscience|February 28, 2024
LuciA-15 - a real-world prospective study of PARP inhibitors for the treatment of patients with HER-2 negative metastatic breast cancer with germline and/or somatic mutation of BRCA genes or homologous recombination repair related genesFernando E Petracci, Cynthia Villarreal-Garza, Facundo Argañaraz, et al.
Oncology Research|June 12, 2023
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective studyGustavo Martín Villoldo, María Teresa Pombo, Mariana Aris, et al.
Pageof 3